FDA Approved: NUEDEXTA — Original Application (Otsuka America Pharmaceutical, Inc)

View source ↗

Summary

FDA approved NUEDEXTA from the Original Application (NDA) for the fixed-dose combination of dextromethorphan hydrobromide and quinidine sulfate. It is indicated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudobulbar Affect

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

ORIG AP for NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)